US plans to regulate e-cigarettes under drug rules; 5 firms get warning letters
This article was originally published in RAJ Devices
The US Food and Drug Administration has announced that it intends to regulate electronic cigarettes as medical products and that these will be deemed combination products and be subject to the agency's drug rules1,2.
You may also be interested in...
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.